Cannabis Movers & Shakers: Leafly, Origin Therapeutics, ECGI Holdings, 22nd Century Group
Cannabis Movers & Shakers: Leafly, Origin Therapeutics, ECGI Holdings, 22nd Century Group
Leafly Hires Rebecca Warner As VP Of Sales
Leafly聘請麗貝卡·華納擔任銷售副總裁
The cannabis information platform Leafly Holdings, Inc. said Wednesday that it has hired Rebecca Warner to serve as senior vice president of sales.
大麻信息平臺Leafly Holdings,Inc.週三表示,它已經聘請麗貝卡·華納(Rebecca Warner)擔任銷售高級副總裁。
In her new role, Warner will oversee the ongoing value creation for brands and retailers that want to reach shoppers on the Leafly platform.
在她的新角色中,華納將監督為希望在Leafly平臺上接觸到購物者的品牌和零售商正在進行的價值創造。
The addition of Warner to the executive team follows several key leadership hires since announcing the company's intent to combine with Merida Merger Corp. I (NASDAQ:MCMJ) earlier this year, including appointments of Suresh Krishnaswamynd and Kimberly Boler, to name a few.
華納加入執行團隊自宣佈公司有意與梅里達合併公司合併以來,該公司的幾名關鍵領導層進行了招聘。(納斯達克:mcmj)今年早些時候,包括任命Suresh Krishnaswamynd和Kimberly Boler,僅舉幾個例子。
Rebecca has over 14 years experience designing and executing sales growth strategies at industry-leading online marketplaces. Most recently, she served as the director of Rental Sales at Zillow Gr (NASDAQ:Z), where she oversaw significant market share growth even through the pandemic. Prior to that, she held director-level roles at Domain, a leading real estate marketplace in Australia.
麗貝卡在設計和執行行業領先的在線市場的銷售增長戰略方面擁有超過14年的經驗。最近,她擔任Zillow Gr(納斯達克:Z),在那裏,她監督着市場份額的顯著增長,即使在大流行期間也是如此。在此之前,她曾在澳大利亞領先的房地產市場Domain擔任董事級別的職務。
"Our vision for Leafly centers on continually reinforcing our role as the marketplace of choice for the cannabis community," Leafly CEO Yoko Miyashita said. "Rebecca's experience driving growth at online marketplaces will be critical as we work to unlock Leafly's full potential to serve our customers and monetize our platform at a greater scale as a public company."
我們對Leafly的願景是繼續加強我們作為大麻社區首選市場的作用。“Leafly首席執行官宮下洋子説。麗貝卡在網上市場推動增長的經驗將是至關重要的,因為我們正在努力釋放Leafly為我們的客户服務的全部潛力,並作為一家上市公司更大規模地將我們的平臺貨幣化。“
Origin Therapeutics Announces Leadership Team
Origin治療公司宣佈領導團隊
Origin Therapeutics Holdings Inc., an investment issuer focused on making equity investments in the psychedelics sector, recently announced its leadership team.
Origin治療控股公司,一家專注於在中國進行股權投資的投資發行人迷幻藥部門,最近宣佈了它的領導團隊。
Created to provide retail investors with the opportunity to participate in the significant growth potential that private companies in the sector have before they would typically go public, the Vancouver-based company hired the following experts:
這家總部位於温哥華的公司成立的目的是為散户投資者提供機會,讓他們有機會參與該行業的私營公司在通常情況下上市之前具有的巨大增長潛力。聘請了以下專家:
- Alexander Somjen, who will serve as CEO, brings extensive experience as an officer and director of publicly listed and privately held companies across a broad range of sectors, including technology, healthcare and cannabis.
- Kelvin Lee, who agreed to oversee Origin's finance department, has more than 15 years of extensive financial management experience with publicly traded companies. He is formerly CFO of Freeman Gold Corp.(CSE:FMAN) (OTCQB:FMANF). Prior to that, he had held senior roles from corporate controller, VP of finance and administration to chief financial officer for a TSXV listed gold producer with $400 million in revenue over nine years.
- Brianna Davies, JD, a corporate securities lawyer with over 14 years experience working as legal counsel, corporate secretary and chief compliance officer to various privately held and publicly traded companies, primarily focused in the resource and technology sectors, will serve as an independent director.
- Michael Young, a founding partner of an investment company Cottingham Capital, agreed to serve as the company's chairperson, advisor and investment committee member.
- Kyle Gould, a co-founder of Hyperion Capital Inc., a boutique advisory firm specializing in the healthcare and technology sectors, agreed to serve as advisor and investment committee member. Prior to founding Hyperion Capital Inc., Gould was a director with GMP Securities L.P.'s cannabis practice where he aided in raising and advising over $10 billion worth of corporate mandates across more than 100 transactions.
- Jaiveer Singh, who agreed to the role of advisor and investment committee member, is the CEO of Mint Pharmaceuticals Inc. and an active early-stage investor. He was the chairman of Truverra Inc. until it was acquired by The Supreme Cannabis Company, Inc. (TSX:FIRE) (OTCQX:SPRWF) in 2019 and is a co-founder of Los Angeles-based hedge fund Medina Singh Partners, LLC.
- Alfred Wong, the company's vice president of investments, is a venture capitalist and entrepreneur with experience in technology, cannabis, pharmaceuticals and consumer goods. Currently, is the managing director at a boutique management consulting firm.
- Jonathan S. Goldman, who brings over 25 years of experience in business, commercial real estate and infrastructure development, will assume the role of advisor.
- 亞歷山大·索姆金誰將擔任首席執行官,在包括技術、醫療保健和大麻在內的廣泛行業中擔任上市和私人持股公司的高級管理人員和董事,具有豐富的經驗。
- 凱爾文·李誰同意監管Origin的財務部門擁有超過15年的上市公司財務管理經驗。他曾擔任中國石油天然氣集團公司的首席財務官。弗里曼黃金公司(CSE:FMAN)(OTCQB:FMANF)。在此之前,他曾在一家在TSXV上市的黃金生產商擔任高級職務,從公司總監、財務和行政副總裁到首席財務官,九年來收入4億美元。
- Brianna Davies,JD是一名公司證券律師,擁有超過14年的法律顧問、公司祕書和首席合規官的工作經驗,曾在多傢俬人持股和上市公司擔任法律顧問、公司祕書和首席合規官,主要專注於資源和技術領域。獨立董事。
- 邁克爾·楊(Michael Young),一家投資公司的創始合夥人科廷漢資本,同意擔任公司董事長、顧問和投資委員會委員。
- 凱爾·古爾德,Hyperion Capital Inc.的聯合創始人。,一家專門從事醫療保健和技術領域的精品諮詢公司,同意擔任顧問、投資委員會委員。在創立Hyperion Capital Inc.之前,古爾德是GMP證券公司他協助籌集了100多筆交易中價值超過100億美元的公司委託,併為其提供諮詢服務。
- 賈維爾·辛格誰同意扮演這樣一個角色顧問兼投資委員會委員,是該公司的首席執行官薄荷製藥公司。也是一位活躍的早期投資者。他是該公司的董事長。Truverra Inc.直到它被最高大麻公司。(多倫多證券交易所股票代碼:FIRE)(OTCQX:SPRWF),是洛杉磯對衝基金的聯合創始人麥地那 辛格合夥公司(Singh Partners,LLC)
- 阿爾弗雷德·王,該公司的投資副總裁,是一位風險投資家和企業家,在技術、大麻、製藥和消費品方面經驗豐富。目前,是一家精品管理諮詢公司的董事總經理。
- 喬納森·S·戈德曼他在商業、商業地產和基礎設施開發方面擁有超過25年的經驗,將擔任顧問的角色。
"The team's strong foundation of experience will enable us to drive the growth of our portfolio companies and support their success with mentorship, connections, and advisory," Somjen said. "We are committed to judicious review and analysis of opportunities to secure the right investments for a solid overall portfolio in the exciting and novel psychedelic field."
Somjen説:“該團隊雄厚的經驗基礎將使我們能夠推動我們投資組合公司的增長,並通過指導、關係和諮詢來支持它們的成功。”我們致力於對機會進行明智的審查和分析,以確保在令人興奮和新穎的迷幻領域獲得可靠的整體投資組合的正確投資。“
ECGI Holdings Bolsters Management Team With CFO Danny Wong
ECGI控股與首席財務官黃丹尼加強管理團隊
ECGI Holdings, Inc. (OTC:ECGI), a Los Angeles-based company that plans to operate as Elite Cannabis Group, announced recently that it has boosted its management team via the retention of Danny Wong as chief financial officer.
ECGI控股公司(場外交易代碼:ECGI),一家總部位於洛杉磯的公司,計劃作為精英大麻集團,該公司最近宣佈,通過保留丹尼·黃(Danny Wong)擔任首席財務官,該公司加強了管理團隊。
Wong, a veteran of the financial services and consulting industries with substantial experience interfacing with C-suite executives at Fortune 500 companies, opted to oversee all aspects of the company's financial management as it continues its transition into the North American cannabis marketplace.
黃是金融服務和諮詢行業的資深人士,擁有與財富500強公司高管打交道的豐富經驗。在該公司繼續向北美大麻市場過渡的過程中,他選擇監督公司財務管理的方方面面。
"Our plans call for strong growth, and to execute upon our plans, it is important to continue growing our executive ranks," the company's CEO William Chung, said. "Danny has the exact type of experience we require to take our operation to the next level. We welcome him to the ECGI team."
“我們的計劃需要強勁的增長,要執行我們的計劃,重要的是繼續壯大我們的高管隊伍,”該公司的行政總裁鍾庭耀,説。“丹尼擁有我們將業務提升到下一階段所需的經驗。我們歡迎他加入ECGI團隊。”
22nd Century Group Announces New CFO
22世紀集團宣佈新的首席財務官
Plant-based biotech company 22nd Century Group, Inc. (NASDAQ:XXII) announced last week that it has tapped Richard Fitzgerald as chief financial officer.
植物性生物技術公司22世紀集團公司。納斯達克(Sequoia Capital:XXII)上週宣佈任命理查德·菲茨傑拉德(Richard Fitzgerald)為首席財務官。
Fitzgerald, who replaces John Franzino, will be responsible for further developing the company's business processes and leading the company's financial planning and analysis, operational finance, human resources and information technology functions as the new chief administrative officer.
菲茨傑拉德,誰替代約翰·弗蘭齊諾將負責進一步發展公司的業務流程,並領導公司的財務規劃和分析、運營財務、人力資源和信息技術職能作為新的首席行政官。
"This is a pivotal time for 22nd Century as we build out our leadership team, particularly with the pending MRTP authorization and international launch of our VLN® product," said James A. Mish, the company's CEO. "Rich brings a diverse background, including extensive experience in IP and technology licensing in the life science industry, which we believe is timely as we execute on our key launch programs in tobacco, hemp/cannabis, and hops."
他説:“現在是22世紀的關鍵時刻,因為我們正在組建我們的領導團隊,特別是在我們的VLN®產品即將獲得MRTP授權和在國際上推出的情況下。”詹姆斯·A·米什(James A.Mish),該公司首席執行官。Rich公司擁有豐富的背景,包括在生命科學行業的知識產權和技術許可方面的豐富經驗,我們相信,這在我們執行煙草、大麻/大麻和啤酒花方面的關鍵推出計劃時是及時的。“
Photo: Courtesy of David Gabrić on Unsplash
圖片:由david gabrić在Unspash上提供
譯文內容由第三人軟體翻譯。